Medicine and Dentistry
Multiple Sclerosis
100%
Messenger RNA
60%
Ibudilast
60%
Cytokine
40%
Combination Therapy
40%
Interferon
40%
Patient
40%
Cells
40%
Phosphodiesterase Inhibitor
40%
Tumor Necrosis Factor
20%
Monotherapy
20%
Real Time Polymerase Chain Reaction
20%
Interleukin 4
20%
Natural Killer T Cell
20%
Th1 Th2 Balance
20%
Experimental Autoimmune Encephalomyelitis
20%
Analysis
20%
Blood
20%
Immunology and Microbiology
Multiple Sclerosis
100%
Ibudilast
60%
Interferon Type I
40%
Natural Killer T Cell
40%
Normal Human
20%
Blood Product
20%
Tumor Necrosis Factor Alpha
20%
CD4
20%
Interleukin 4
20%
Real Time Polymerase Chain Reaction
20%
Th1 Th2 Balance
20%
Experimental Autoimmune Encephalomyelitis
20%
Dose
20%
Cells
20%
Flow
20%
Pharmacology, Toxicology and Pharmaceutical Science
Multiple Sclerosis
100%
Messenger RNA
60%
Ibudilast
60%
Interferon
40%
Cytokine
40%
Phosphodiesterase Inhibitor
40%
Normal Human
20%
Monotherapy
20%
Interleukin 4
20%
Experimental Autoimmune Encephalomyelitis
20%
Tumor Necrosis Factor
20%
Neuroscience
Multiple Sclerosis
100%
Ibudilast
60%
Interferon
40%
Phosphodiesterase Inhibitor
40%
Tumor Necrosis Factor Alpha
20%
CD4
20%
Real-Time Polymerase Chain Reaction
20%
Interleukin 4
20%
Experimental Autoimmune Encephalomyelitis
20%
Biochemistry, Genetics and Molecular Biology
Messenger RNA
60%
Cytokine
40%
Interferon
40%
Normal Human
20%
Real-Time Polymerase Chain Reaction
20%
CD4
20%
Tumor Necrosis Factors
20%
Interleukin 4
20%
Th1 Th2 Balance
20%
Natural Killer T Cell
20%
Animal Models
20%
Dose
20%
Flow
20%